Press Release

Cell Counting Market to Grow with a CAGR of 8.00% through 2028

Advances in cell-based research and the increasing role of cell counting in clinical diagnostics is expected to drive the Global Cell Counting Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Cell Counting Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Cell Counting Market stood at USD 8.19 billion in 2022 and is anticipated to grow with a CAGR of 8.00% in the forecast period, 2024-2028. This can be attributed to growth in clinical diagnostics. Cell counting is not limited to research and biopharmaceutical applications. Clinical diagnostics, including hematology, pathology, and cancer research, rely on accurate cell counting to make critical medical decisions. The increasing prevalence of chronic diseases and the need for precise cell counting in diagnostic tests are contributing to the market's growth. Automated hematology analyzers and flow cytometry systems are becoming indispensable tools in healthcare institutions, aiding in the rapid and accurate analysis of blood samples and cell populations.

Furthermore, biopharmaceutical companies are increasingly relying on cell counting for bioprocessing and quality control. This trend ensures the consistency and quality of biologic products, such as monoclonal antibodies and vaccines. As biopharmaceuticals continue to grow, so does the demand for advanced cell counting solutions.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Cell Counting Market

 

The market experienced a significant impact from the COVID-19 pandemic. The utilization of cell counting devices saw a notable surge during the pandemic, primarily because conditions like lymphopenia and osteopenia were potential indicators of COVID-19. Furthermore, a study published by BMC in June 2021 established a significant correlation between the white blood cell (WBC) count of COVID-19 patients upon admission and their likelihood of mortality. Patients with higher white blood cell counts required extra attention in their COVID-19 treatment. The growing significance of cell counting in managing COVID-19 patients contributed to market growth during the pandemic. Cell counting instruments are increasingly finding applications in various research fields such as neuroscience, cancer biology, and immunology, offering promising growth opportunities for the market.

Cell counting plays a crucial role in identifying and quantifying primary tumors, circulating tumors, and metastatic tumors, which are vital for disease monitoring and therapeutic targeting. Additionally, they are extensively employed in cancer research to assess intra-tumor heterogeneity, a critical factor in determining cancer progression. The adoption of cell counting is anticipated to rise over the forecast period as it is essential for diagnosing various diseases.

Moreover, technological advancements in these devices present lucrative opportunities during the study period. For example, in January 2023, DeNovix's automated cell counter, CellDrop, received recognition as the Sustainable Laboratory Product of the Year in the SelectScience Scientists' Choice Awards. This accolade is due to its innovation in eliminating the need for cell counting slides, resulting in the conservation of 8.5 million slides, equivalent to 30,000 kg of plastic. In April 2021, CytoSMART Technologies launched their first fluorescence cell counter, CytoSMART Exact FL, offering dual fluorescence capabilities for typical laboratory applications. In December 2020, Merck introduced Scepter 3.0, an automated handheld cell counter known for its remarkable accuracy in counting thousands of cells per measurement. Similarly, in June 2020, DeNovix introduced the industry's first imaging cell counter, which eliminates the requirement for slides, thereby reducing the environmental impact of laboratory operations.

Government initiatives aimed at promoting cell therapeutics research are expanding growth opportunities in the market. Additionally, increased funding for stem cell research in recent years has accelerated research efforts. For instance, in March 2023, the Stem Cell Research and the Eli and Edythe Broad Center of Regenerative Medicine at UCLA received more than USD 5.7 million in funding from the California Institute for Regenerative Medicine to enhance stem cell-based technologies for treating cancer and intellectual disabilities.

The Global Cell Counting Market is segmented into product, application, end-use, regional distribution, and company.

Based on its product, the consumables and accessories sector dominated the revenue landscape in 2022, and it is poised to exhibit the most rapid CAGR throughout the projected period. These consumables and accessories encompass various items such as reagents, microplates, magnetic beads, and chamber slides, all of which are used in conjunction with specific devices. The upswing in demand for these consumables and accessories can be attributed to their significant usage frequency. Additionally, the introduction of innovative products has been a driving force behind the growth of this segment. As an illustrative example, eNuvio launched a reusable 3D cell culture microplate in December 2020, with the expectation that scientists would reap both economic and scientific benefits from this environmentally friendly device for an extended duration.

Furthermore, within this segment, the reagents sub-category claimed the largest portion of revenue in 2022. This substantial revenue share can be attributed to the recurring procurement of these products for applications in spectrophotometry, flow cytometry, and automated cell counting. The necessity for frequent recalibrations of these instruments before conducting experiments has bolstered their demand. Notably, Corning's automated Cell Counter simplifies this process by seamlessly connecting the device with a tablet or computer via the CytoSMART Cloud App. This system promptly generates summary reports after each count, which can be conveniently accessed remotely on various devices.

Based on end-use, the major chunk of the revenue was contributed by research and academic institutions. The primary reason for this dominant position can be traced back to the widespread adoption of cytometers in cell biology research endeavors. Cytometers serve various purposes, including measuring physical characteristics, cell types, and lineages. These measurements are pivotal for researchers in studying the progression of viruses, pathogens, and other microorganisms. Additionally, the proactive initiatives taken by key players in the market further bolster this segment. As an example, in March 2021, Alliance Global successfully implemented an Automated Cell Counter system at the United Arab Emirates University in Al Ain.

Conversely, the hospitals and diagnostic laboratories sector is expected to exhibit a significant CAGR over the forecast period. This growth can be attributed to the substantial foot traffic in hospitals and the increasing adoption of advanced technological devices in diagnostic laboratories. In July 2021, Neuberg Diagnostics Private Limited, a prominent pathology organization in India, expanded its presence in the country by inaugurating a pathology lab in Telangana.

Furthermore, the pharmaceutical and biotechnology companies sector is anticipated to experience the fastest CAGR during the forecast period. Cell counting holds a crucial role in assessing the potency of any biological product. These devices are employed to ascertain the cell count in a specific culture solution, which is subsequently introduced into bioreactors and fermenters to achieve the desired end product. The growing demand for biologics manufactured through bioprocessing in these bioreactors and fermenters is expected to drive increased demand for these devices in the coming years.

 

Major companies operating in Global Cell Counting Market are:

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Agilent Technologies, Inc.
  • PerkinElmer Health Sciences Inc
  • Becton Dickinson & Co
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • BioTek Instruments Inc
  • GE Healthcare Inc
  • deNovis Inc

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“the global cell counting market is witnessing exciting trends that are shaping the future of this essential technology. The trends are enhancing precision, accessibility, and applications across a wide range of industries, from healthcare to biotechnology and environmental science. As technology continues to advance and as new challenges arise, the global cell counting market will remain at the forefront of innovation, playing a pivotal role in the advancement of science and healthcare,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Cell Counting Market By Product (Instruments (Spectrophotometers, Flow Cytometers, Hemocytometers, Automated cell counters, Microscopes, Others), Consumables & Accessories (Reagents, Microplates, Others)), By Application (Complete Blood Count (Automated, Manual), Stem Cell Research, Cell Based Therapeutics, Bioprocessing, Toxicology, Others), By End-use (Hospitals &Diagnostic Laboratories, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Cell Counting Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Cell Counting Market.


Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com

Relevant News